AC Immune’s Interim Phase 2 Results Highlight Promising Slowdown in Parkinson’s Disease Progression
Market Chameleon (Fri, 12-Dec 10:32 AM)
AC Immune’s Phase 2 Data Suggests Potential to Slow Parkinson’s Progression with ACI-7104.056
Market Chameleon (Thu, 11-Dec 10:32 AM)
